Pineapple Express Cannabis (PNXP) Equity Average (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Equity Average came in at -$8.2 million in Q4 2025, down 28136.28% year-on-year from N/an in Q4 2024, and little changed quarter-over-quarter from -$8.2 million in Q3 2025.
Pineapple Express Cannabis (PNXP) Equity Average (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Equity Average across 8 years of filings, most recently posting -$8.2 million for Q4 2025.
- Equity Average for Q4 2025 came in at -$8.2 million, down 28136.28% year-over-year; the trailing twelve-month figure through Oct 2025 was -$8.2 million (down 28136.28% YoY), and the FY2025 annual result was -$9002.5, up 96.79% from the prior year.
- Equity Average came in at -$8.2 million for Q4 2025 at Pineapple Express Cannabis, roughly flat from -$8.2 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $989739.0 in Q4 2023 to a low of -$8.2 million in Q3 2025.
- The 5-year median for Equity Average is -$46761.5 (2021), against an average of -$953809.1.
- Across the five-year window, Equity Average soared 1560.3% in 2023 and plunged 86221.06% in 2025, its largest moves.
- Pineapple Express Cannabis' Equity Average stood at -$52991.5 in 2021, then dropped by 27.9% to -$67776.5 in 2022, then jumped by 1560.3% to $989739.0 in 2023, then sank by 97.06% to $29126.0 in 2024, then sank by 28136.28% to -$8.2 million in 2025.
- The last three Equity Average figures came in at -$8.2 million (Q4 2025), -$8.2 million (Q3 2025), and -$4.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | Pineapple Express Cannabis | - | - | - | -8.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -8.17 Mn |
| Jul 31, 2025 | -8.19 Mn |
| Apr 30, 2025 | -4.10 Mn |
| Jan 31, 2025 | 13,211.50 |
| Oct 31, 2024 | 29,126.00 |
| Jul 31, 2024 | 27,604.00 |
| Apr 30, 2024 | 4,766.00 |
| Jan 31, 2024 | 522,197.00 |
| Oct 31, 2023 | 989,739.00 |
| Jul 31, 2023 | 612,201.50 |
| Apr 30, 2023 | -119,552.50 |
| Jan 31, 2023 | -307,005.50 |
| Oct 31, 2022 | -67,776.50 |
| Jul 31, 2022 | -65,212.00 |
| Apr 30, 2022 | -61,718.50 |
| Jan 31, 2022 | -56,205.00 |
| Oct 31, 2021 | -52,991.50 |
| Jul 31, 2021 | -40,531.50 |
| Apr 30, 2021 | -22,249.00 |
| Jan 31, 2021 | -19,121.00 |